Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,267
  • Shares Outstanding, K 16,979
  • Annual Sales, $ 13,370 K
  • Annual Income, $ -9,950 K
  • 60-Month Beta 0.11
  • Price/Sales 0.55
  • Price/Cash Flow N/A
  • Price/Book 1.60
Trade APDN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.79
  • Most Recent Earnings $-0.09 on 02/08/24
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 111.14%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,420.54% on 02/12/24
  • IV Low 0.00% on 03/27/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 20
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 1,182
  • Open Int (30-Day) 1,209

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 1
  • High Estimate -0.23
  • Low Estimate -0.23
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3680 +11.41%
on 03/15/24
0.6190 -33.76%
on 02/29/24
-0.1860 (-31.21%)
since 02/28/24
3-Month
0.3680 +11.41%
on 03/15/24
0.7200 -43.06%
on 02/23/24
-0.2300 (-35.94%)
since 12/28/23
52-Week
0.3680 +11.41%
on 03/15/24
1.8600 -77.96%
on 08/01/23
-0.6900 (-62.73%)
since 03/28/23

Most Recent Stories

More News
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

APDN : 0.4100 (-4.21%)
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times -

APDN : 0.4100 (-4.21%)
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot

Applied DNA Sciences: Fiscal Q4 Earnings Snapshot

APDN : 0.4100 (-4.21%)
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results

- Conference Call/Webcast Scheduled for Today at 4:30 PM ET -

APDN : 0.4100 (-4.21%)
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023

STONY BROOK, NY / ACCESSWIRE / December 5, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced...

APDN : 0.4100 (-4.21%)
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application

STONY BROOK, NY / ACCESSWIRE / November 28, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the receipt of a follow-on...

APDN : 0.4100 (-4.21%)
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)

- Extension Increases Total Addressable Market to Include Both Conventional Non-Amplifying mRNA and saRNA -

APDN : 0.4100 (-4.21%)
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

- Preclinical Orders for Additional Customers Underway -

APDN : 0.4100 (-4.21%)
Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals

Agreement Focuses on the Accelerated Development of LNP-encapsulated LineaDNAâ„¢ Vaccines to Eliminate the Use of Plasmid DNA and Reduce the Dependence on Extreme Cold Chains of Today's mRNA Vaccines

APDN : 0.4100 (-4.21%)
Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs

Experienced Biopharma/Pharmaceutical Executive to Lead Implementation of cGMP-quality LineaDNAâ„¢ Capability for IVT mRNA Production

APDN : 0.4100 (-4.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

3rd Resistance Point 0.4767
2nd Resistance Point 0.4633
1st Resistance Point 0.4367
Last Price 0.4100
1st Support Level 0.3967
2nd Support Level 0.3833
3rd Support Level 0.3567

See More

52-Week High 1.8600
Fibonacci 61.8% 1.2901
Fibonacci 50% 1.1140
Fibonacci 38.2% 0.9379
Last Price 0.4100
52-Week Low 0.3680

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar